Literature DB >> 2246906

National survey of the pattern of care for carcinoma of the lung.

E W Humphrey1, C R Smart, D P Winchester, G D Steele, J W Yarbro, K C Chu, H H Triolo.   

Abstract

A national survey of the patterns of care for carcinoma of the lung sponsored by the Commission on Cancer of the American College of Surgeons has documented continuing changes in epidemiology, treatment, and outcome. The project consisted of a long-term study of 15,219 patients whose diagnosis was made in 1981 and a short-term study of 19,074 patients whose diagnosis was made in 1986. The male/female incidence ratios have continued to decrease and the decrease has moved into the older age groups. Although the percentage of adenocarcinoma is increasing at the expense of squamous carcinoma, the latter is still the most prevalent histologic type. The accuracy of percutaneous needle biopsy and transbronchial biopsy of lung nodules reported from this group of 941 hospitals was high and equal to that reported by single institutions. The percentage of patients having a resection did not increase from 1981 to 1986, but for smaller lesions a move was apparent toward more lung-sparing resections. Little change has occurred in the use of adjuvant radiotherapy, particularly in stage III disease, where approximately 50% of the patients received postoperative irradiation. An improvement in the overall 5-year survival when compared with Surveillance, Epidemiology, and End Results data was noted. Whether this is a true improvement in survival or is the result of selection because of an unrecognized change in the pattern of care for patients with a carcinoma of the lung is unknown.

Entities:  

Mesh:

Year:  1990        PMID: 2246906

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  10 in total

1.  BTS guidelines: guidelines on the selection of patients with lung cancer for surgery.

Authors: 
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

2.  The practice of cardiothoracic surgeons in the perioperative staging of non-small cell lung cancer.

Authors:  G M Tsang; D C Watson
Journal:  Thorax       Date:  1992-01       Impact factor: 9.139

Review 3.  Management of lung cancer.

Authors:  M F Muers; R A Haward
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

4.  Interval lung cancers not detected on screening chest X-rays: How are they different?

Authors:  Paul A Kvale; Christine Cole Johnson; Martin Tammemägi; Pamela M Marcus; Carl J Zylak; David L Spizarny; William Hocking; Martin Oken; John Commins; Lawrence Ragard; Ping Hu; Christine Berg; Philip Prorok
Journal:  Lung Cancer       Date:  2014-07-24       Impact factor: 5.705

5.  Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study.

Authors:  A Gregor; C S Thomson; D H Brewster; P L Stroner; J Davidson; R J Fergusson; R Milroy
Journal:  Thorax       Date:  2001-03       Impact factor: 9.139

6.  Improving surgical resection rate in lung cancer.

Authors:  C Laroche; F Wells; R Coulden; S Stewart; M Goddard; E Lowry; A Price; D Gilligan
Journal:  Thorax       Date:  1998-06       Impact factor: 9.139

Review 7.  Extended resection for higher-stage non-small-cell lung cancer.

Authors:  J D Luketich; D E van Raemdonck; R J Ginsberg
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

8.  'Tumour volume' as a predictor of survival after resection of non-small-cell lung cancer (NSCLC)

Authors:  M F Jefferson; N Pendleton; E B Faragher; G R Dixon; M W Myskow; M A Horan
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

9.  Lung cancer patients have increased 8-hydroxydeoxyguanosine levels in peripheral lung tissue DNA.

Authors:  M Inoue; T Osaki; M Noguchi; S Hirohashi; K Yasumoto; H Kasai
Journal:  Jpn J Cancer Res       Date:  1998-07

10.  Divergent changes in survival for histological types of non-small-cell lung cancer in the southeastern area of The Netherlands since 1975.

Authors:  M L Janssen-Heijnen; R M Schipper; P J Klinkhamer; M A Crommelin; W J Mooi; J W Coebergh
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.